Vertex Pharmaceuticals (VRTX) Fails to deliver data

Key failure to deliver metrics for Vertex Pharmaceuticals:

• Last SEC data release: 2025-11-28
• Last 15 days FTD volume: €28.2 M
• Last 3 months FTD volume: €46.07 M
• Last 12 months FTD volume: €0.10 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Vertex Pharmaceuticals (VRTX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Vertex Pharmaceuticals (VRTX) - since 2013

Vertex Pharmaceuticals (VRTX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	€36.76 M	€0.25 B	🇺🇸 USA
AbbVie ABBV	€22.48 M	€0.10 B	🇺🇸 USA
Merck MRK	€17.08 M	€0.16 B	🇺🇸 USA
Bristol-Myers Squibb BMY	€5.67 M	€0.20 B	🇺🇸 USA
Johnson & Johnson JNJ	€57.52 M	€0.10 B	🇺🇸 USA
Enanta Pharmaceuticals ENTA	€0.58 M	€0.99 M	🇺🇸 USA